omega-n-methylarginine has been researched along with methyl 3,5-di-o-caffeoyl quinate in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (methyl 3,5-di-o-caffeoyl quinate) | Trials (methyl 3,5-di-o-caffeoyl quinate) | Recent Studies (post-2010) (methyl 3,5-di-o-caffeoyl quinate) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 11 | 0 | 8 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | methyl 3,5-di-o-caffeoyl quinate (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 4 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 1 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 7 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 2 | Homo sapiens (human) | 6.29 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 11 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 8 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 6 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 9 | Homo sapiens (human) | 6.29 | |
| Histone deacetylase 5 | Homo sapiens (human) | 6.29 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SY; Lee, KR; Lee, SY; Moon, E | 1 |
1 other study(ies) available for omega-n-methylarginine and methyl 3,5-di-o-caffeoyl quinate
| Article | Year |
|---|---|
Quinic acid derivatives from Pimpinella brachycarpa exert anti-neuroinflammatory activity in lipopolysaccharide-induced microglia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Dose-Response Relationship, Drug; Lipopolysaccharides; Mice; Microglia; Molecular Structure; Nitric Oxide; Pimpinella; Plant Extracts; Quinic Acid; Structure-Activity Relationship | 2013 |